Psyence Biomedical (PBM) Receivables - Other (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly Receivables - Other of $174187.0 in Q3 2025, up 26.82% quarter-over-quarter from $137348.0 in Q1 2025, and up 39.26% on a YoY basis from $125080.0 in Q3 2024.
Psyence Biomedical (PBM) Receivables - Other (2023 - 2025) Analysis & Trends
Psyence Biomedical's Receivables - Other history runs 3 years deep, the most recent figure standing at $174187.0 for Q3 2025.
- In Q3 2025, Receivables - Other rose 39.26% year-over-year to $174187.0; the TTM figure through Sep 2025 stood at $174187.0 (up 39.26% YoY), while the FY2025 annual figure was $137348.0, up 229.0% from the prior year.
- Receivables - Other was $174187.0 for Q3 2025 at Psyence Biomedical, up from $137348.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $174187.0 in Q3 2025 to a low of -$109858.0 in Q1 2023.
- Historically, Receivables - Other has averaged $73700.8 across 3 years, with a median of $125080.0 in 2024.
- Biggest YoY gain for Receivables - Other was 229.0% in 2025; the steepest drop was 39.26% in 2025.
- A 3-year view of Receivables - Other shows it stood at -$109858.0 in 2023, then soared by 213.86% to $125080.0 in 2024, then jumped by 39.26% to $174187.0 in 2025.
- The last three Receivables - Other figures came in at $174187.0 (Q3 2025), $137348.0 (Q1 2025), and $125080.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 174,187.00 |
| Sep 30, 2025 | 174,187.00 |
| Mar 31, 2025 | 137,348.00 |
| Mar 31, 2025 | 137,348.00 |
| Sep 30, 2024 | 125,080.00 |
| Sep 30, 2024 | 125,080.00 |
| Mar 31, 2024 | 41,747.00 |
| Mar 31, 2024 | 41,747.00 |
| Mar 31, 2023 | -109,858.00 |
| Mar 31, 2023 | -109,858.00 |